We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Malaria Parasitaemia Correlated with Monocyte to Lymphocyte Ratio

By LabMedica International staff writers
Posted on 28 Nov 2018
In spite of a declining trend in the number of cases and deaths over the last few years, malaria still causes significant mortality and morbidity and the bulk of the burden is observed in children under five years of age.

During the course of malaria infection, parasites and red blood cells come under oxidative stress and there is host immune response in an attempt to protect the red blood cells. More...
The frequency of monocytes and lymphocytes in peripheral blood might, therefore, be expected to reflect the state of an individual’s immune response to the infection.

Medical laboratory scientists at the University of Ghana (Accra, Ghana) conducted a case control study between the years 2014 and 2017, that included children, both male and female up to five years and four months old attending the selected hospitals and presenting with clinical malaria as cases and apparently healthy pre-school and school children undergoing health screening as the controls. Venous blood sample were taken from participants by phlebotomy into anticoagulant tubes. Thick and thin blood films were made and stained with Giemsa and examined for malaria parasites.

For hematological analysis, whole blood specimens were analyzed for full blood count using ABX Pentra 60 C+ automated hematological analyzer and the result used to estimate the monocytes and lymphocytes ratio of each participant. Also the thin smears were examined to confirm the morphology of the cells. The absolute count of the monocytes and lymphocytes level of each sample was entered into a calculator and the ratio was estimated by dividing the monocytes by the lymphocyte counts. The other ratios were calculated using the same formula.

The study comprised of 1,629 (males = 55%) children presenting with clinical malaria as cases and 445 (males = 57.7%) apparently healthy children as controls. Blood samples from the malaria patients showed positive blood smear for malaria parasites, while no parasites were found in the healthy control subjects. There was a significant difference between lymphocytes of the case group and that of the controls and there was also significant difference between the monocytes to lymphocytes ratio of the cases and controls. Significant difference in neutrophil to lymphocyte ratios between the two study groups was also observed.

The authors concluded that the monocyte to lymphocyte ratio obtained correlated positively with the presence of malaria as well as the level of parasitaemia. The outcome of this work implies that monocyte to lymphocyte ratio can be used to predict the level of parasitaemia and together with other factors, the development of severe malaria. The study was published on November 12, 2018, in the Malaria Journal.

Related Links:
University of Ghana


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.